Understanding how T cells develop differently before and after birth
Molecular basis for contrasting programs of fetal and adult T cell development
This project explores how our immune system's T cells form in unique ways when we are developing in the womb compared to when we are adults.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | California Institute of Technology NIH-funded |
| Lab location | 1 site (Pasadena, United States) |
| Project ID | NIH-11228302 on NIH RePORTER |
What this research studies
Our immune system relies on T cells, which are special white blood cells made in the thymus throughout our lives. This project aims to uncover the distinct genetic and molecular instructions that guide T cell development in unborn babies versus adults. Researchers are looking at why T cells made early in life develop faster and create unique types of immune cells compared to those made later. By understanding these fundamental differences, we can gain insights into how our immune system is built and functions from the very beginning.
Who could benefit from this research
Good fit: This basic science project does not directly involve patient participation, but future studies building on this work might seek individuals with specific immune conditions or those interested in donating samples.
Not a fit: Patients seeking immediate treatment or direct clinical intervention will not find direct benefit from this foundational research.
Why it matters
Potential benefit: Understanding these fundamental differences in T cell development could lead to new ways to improve immune health, treat immune disorders, or develop better vaccines for people of all ages.
How similar studies have performed: This project builds upon existing knowledge of T cell biology but aims to uncover novel molecular mechanisms explaining the distinct developmental programs.
Where this research is happening
Pasadena, United States
- California Institute of Technology — Pasadena, United States (Active)
Researchers
- Principal investigator: Rothenberg, Ellen V. — California Institute of Technology
- Study coordinator: Rothenberg, Ellen V.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.